NCT07461181 2026-03-10
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2 Active not recruiting
Ruijin Hospital
Suzhou Genhouse Bio Co., Ltd.
University Medical Center Groningen
Chinese PLA General Hospital
Shanghai East Hospital